April 2019

Date：

2023-07-17

The company was successfully listed in the Anhui Equity Trusteeship Trading Center, listing code: 630215, marking that the company has officially entered the listing incubation period, laying a solid foundation for the company to achieve its strategic goals;

Related News

2024-01-22

Serving the big health industry, leapfrogging development of industry, academia and research - Anhui Huibang Biotech bloomed at the Anhui Traditional Chinese Medicine Academic Annual Conference

2023-08-07

Urine and nephropathy and defense -Dialogue column of the Diabetes Branch of the Chinese Medical Association

On August 4, 2023, the Chinese Medical Association Diabetes Branch 2023 Education Management Academic Conference was grandly held at Fengda International Hotel, Hefei City, Anhui Province.

2023-06-29

Good news! Huibang Biotechnology won the second prize of Science and Technology Progress Award of the Ministry of Education!

Recently, the Ministry of Education issued a certificate for the Outstanding Achievement Award (Science and Technology) of Scientific Research in Institutions of Higher Learning. Anhui Huibang Bioengineering Co., Ltd. jointly with the Chinese Academy of Sciences and Capital Medical University declared the project: "Research and Application of Molecular Targets for Diabetes" won the second prize of Science and Technology Progress Award of the Ministry of Education.

2023-06-12

Huibang Biotech actively implements the Hangzhou Declaration and contributes to building a healthy China

On June 11, 2023, the first China Health Promotion Conference was successfully held in Hangzhou. The conference was high-level and large-scale, and many guests from the government, medical and health circles, sports circles, education circles, science and technology circles, mass media, NGO organizations and business circles attended.

2023-06-01

Good news! Huibang Biotechnology won the "Star of Creation" Cup Innovative Product Gold Award

Wisdom medicine is upright and innovative | "Star of Creation" The 8th China Experimental Medicine Conference was grandly opened on May 27 at the Primus Hotel Conference Center in Nanchang! Huibang Bio's innovative product insulin-like growth factor binding protein-1/fetal fiber Connexin (IGFBP-1/fFN) detection kit won the 2022 "Innovation Star" Cup China Excellent Innovative Product Gold Award for In Vitro Diagnostics.